SCHEMBL7709375

SCHEMBL7709375

O=C(O)COc1ccc(C2CC(=O)N(Cc3ccc(Cl)cc3)C2)c2c1oc1ccccc12

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.58
ALDH1A1 P00352 2/20 0.43
MAPT P10636 3/20 0.41
HPGD P15428 2/20 0.39
TSHR P16473 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
PTPN1 P18031 1/20 0.37
KDM4E B2RXH2 2/20 0.36
PTGDR2 Q9Y5Y4 2/20 0.36
GAA P10253 1/20 0.36
PTGDR Q13258 1/20 0.36
PKM P14618 2/20 0.36
P2RX7 Q99572 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8272028 0.87 PDE10A (0.75) PDE10AALDH1A1MAPTHPGDTSHR
SCHEMBL7709951 0.84 PDE10A (0.56) PDE10AMAPTHPGDTSHRPDE4A
SCHEMBL7705002 0.84 PDE10A (0.56) PDE10AALDH1A1MAPTHPGDTSHR
SCHEMBL7703632 0.84 PDE10A (0.59) PDE10AMAPTHPGDTSHRPDE4A
SCHEMBL8271910 0.79 PDE10A (0.73) PDE10AALDH1A1HPGDTSHRPDE4A
SCHEMBL7709755 0.79 PDE10A (0.73) PDE10AALDH1A1HPGDTSHRPDE4A
SCHEMBL8271493 0.78 PDE10A (0.65) PDE10AALDH1A1HPGDPDE4APDE4B
SCHEMBL8271482 0.78 PDE10A (0.71) PDE10AALDH1A1HPGDTSHRPDE4A
SCHEMBL2560664 0.77 PDE10A (0.70) PDE10AALDH1A1HPGDTSHRPDE4A
SCHEMBL2577947 0.76 PDE10A (0.79) PDE10ATSHRPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO disclosed